Our research showed that CXCL3 was significantly overexpressed in the CD133+ CSC population compared with its corresponding CD133− non-CSC population, and CXCL3 expression was positively correlated with CD133 expression in HCC. This evidence concerns the gene CXCL3 and hepatocellular carcinoma.